Biosimilars Series: Stakeholder Analysis

By Author: Manjula Menon
Total Articles: 1486
Comment this article

Although Europe is leading the way, the biosimilar industry is very much in its infancy, with the perception of key decision makers critical to the initial rate of uptake. The opinion of key stakeholders, and the influence they wield, will therefore inform the strategy of both the branded and biosimilar contingents, in what is likely to become a battle to gain trust.

Scope of this report

An overview of the key drivers and resistors to biosimilar use.

An outline of the key stakeholders in Europe and the US, and relative influence they have.

An insight into the opinion of payers, physicians and hospital pharmacists, regarding biosimilar use.

An understanding of how the industry will develop, and the strategies to be employed by the pro and anti biosimilar factions.

Research and analysis highlights

Biologics use is set to grow, at a rate that far outstrips that of small molecule drugs. The considerably greater cost of biologics will therefore combine with increased utilization to put payers under pressure to promote biosimilar use.

Due to the complexity of biologic drugs, ...
... there are greater concerns regarding biosimilar safety and efficacy compared with standard generics, which are likely to only be alleviated following time on the market. Consequently, initial uptake will be greatly influenced by the perceptions of key stakeholders.

The opinion of physicians is considered important by both branded and biosimilar companies, and in Europe this group currently holds the most power. Although motivated to promote generics, payers and pharmacists to an extent, often defer to physicians in Europe, although there is evidence this is not the case in the US.

For more information Kindly visit the website : http://www.bharatbook.com/detail.asp?id=82013

Or Contact us on :
Tel No : (+9122 )27578668 , 27579438
Fax: (+9122 )27579131

Address :
Bharat Book Bureau,
207,Hermes Atrium,
Sector-11
P.O Box 54,
CBD Belapur,
Navi Mumbai - 400614.

Bharat BooK Bureau is the leading market research information aggregator which provides reports, Company profiles, newletters, country info. and online databases for the past twenty years to corportate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies. It helps global companies to know different market before starting up business / expanding in different countries across the world. www.bharatbook.com is one stop shop for the business intelligence information requirements.